Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Breast Neoplasms 8Rectal Neoplasms 5Lung Neoplasms 4Esophageal Neoplasms 4Colorectal Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Adenocarcinoma Of Esophagus 4Colonic Neoplasms 3Central Nervous System Neoplasms 3Breast Neoplasms, Male 3Brain Neoplasms 3Sarcoma 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Osteosarcoma 2Lymphoma 2Head and Neck Neoplasms 2Glioblastoma 2Breast Carcinoma In Situ 2Vomiting 1Teratoma 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Radiation Injuries 1Peritoneal Neoplasms 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasm Metastasis 1Nausea 1Medulloblastoma 1

Interventions

Temozolomide 53Bevacizumab 33Radiotherapy 27Radiation 12Erlotinib Hydrochloride 12Radiotherapy, Intensity-Modulated 8Radiotherapy, Conformal 8Irinotecan 6Vorinostat 5Sorafenib 5Sirolimus 5temsirolimus 4Magnetic Resonance Spectroscopy 4Immunoglobulin G 4Disulfides 4Carmustine 4veliparib 3plerixafor 3carmustine, poliferprosan 20 drug combination 3Radiosurgery 3Everolimus 3Dasatinib 3Bortezomib 3vandetanib 2tandutinib 2sargramostim 2poly ICLC 2pembrolizumab 2pazopanib 2ferric pyrophosphate 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Gliosarcoma × Chemotherapy, Adjuvant × Clear all
NCT01310868 2017-10-05

Gliadel Wafer and Fluorescence-Guided Surgery With 5-ALA Followed by Radiation Therapy And Temozolomide in Treating Patients With Primary Glioblastoma

University College, London

Phase 2 Completed
59 enrolled 8 charts
CNSSarcoma

Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡